Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Symptomatic hypomagnesaemia deficiency
Age: Adult
Dose: Intravenous – 1-2 g
Frequency: over 5-60 minutes, then maintain at 0.5-1 g/hour if needed
Indication: Severe hypomagnesaemia deficiency
Age: Adult
Dose: Intravenous – 1-2 g/hour
Duration: for 3-6 hours, then 0.5-1 g/hour as needed to correct deficiency

Child Dose

Clinical InformationAdministration Information
Indication: Hypomagnesaemia
Age: 4 weeks–18 years
Dose: Intravenous or Intraosseous – 0.1–0.2 mmol/kg (up to 0.4 mmol/kg in severe cases)
Frequency: Up to every 6 hours
Note: Max Dose: 8 mmol per dose
Indication: Hypomagnesaemia
Age: 4 weeks–18 years
Dose: By mouth – Initially 0.1–0.2 mmol/kg
Frequency: 3 times daily
Administration
  • Hospital use only
  • Given by healthcare provider
Side Effect

Drug Interaction

Drug NameRisk Factors
Neuromuscular blockers, Digitalis glycosides
Enhances effects

Disease Interaction

Disease NameRisk Factors
Heart block
Can worsen conduction
Severe renal impairment
Risk of magnesium toxicity

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at controlled room temperature. Protect from light. This IV infusion is not intended for multi-dose use.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.